Infectious disease and antimicrobial resistance
4 European H2020 organizations list this as part of their work.
Most active in this area
- ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM
Leading Dutch university medical center specializing in personalised medicine, life-course epidemiology, and FAIR health data infrastructure across 173 H2020 projects.
“COMPARE addressed foodborne outbreak detection; DIAGORAS developed point-of-care diagnostics for antibiotic resistance; VIROGENESIS used metagenomics for virus discovery.”
NL173 projects - STICHTING AMSTERDAM UMC
Major Dutch academic medical center leading European research in cancer biomarkers, neurodegeneration, precision medicine, and advanced clinical imaging.
“EAVI2020 (AIDS vaccine), EHVA (HIV vaccine alliance), SEPCELL (severe sepsis stem cell therapy), plus growing cluster of antimicrobial resistance projects in later years.”
NL144 projects - UNIVERSITAETSKLINIKUM TUEBINGEN
German university hospital providing clinical trial sites and patient cohorts across pediatrics, stroke, rare diseases, infectious disease, and vaccine development in European consortia.
“PRONKJEWAIL addresses infection susceptibility and antimicrobial resistance, while Prevent-nCoV developed a virus-like particle vaccine against SARS-CoV-2.”
DE7 projects - QUEEN MARGARET UNIVERSITY, EDINBURGH
Scottish university specialising in health communication, speech sciences, community inclusion, and public engagement with advanced therapies.
“PRONKJEWAIL addressed susceptibility to infections, microbiome research, vaccines, and personalized detection/treatment of antimicrobial resistance.”
UK4 projects